pharma · Chronic Kidney Disease Stage 5 (Dialysis Dependent) · bile acid diarrhoea (BAD)
Cosmo Pharmaceuticals
Cosmo Technologies Ltd
Cosmo Technologies is a pharma organization headquartered in GB. Primary therapeutic focus areas include Chronic Kidney Disease Stage 5 (Dialysis Dependent), bile acid diarrhoea (BAD). NovaPharmaNews links 3 clinical pro
Dublin, IE HQ
1997 Founded
255 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dublin, IE
- Founded
- 1997
- Employees
- 255
- Programs
- 3
- Drugs
- 15
- Patents
- 0
Monofer
Phase 3 · small molecule · Chronic Kidney Disease Stage 5 (Dialysis Dependent)
Monofer for Chronic Kidney Disease Stage 5 (Dialysis Dependent) is a Phase 3 program (small_molecule) at Cosmo Technologies Ltd with 1 ClinicalTrials.gov record(s).
Internal code P-Monofer-CKD-03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cosmo Technologies Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Chronic Kidney Disease Stage 5 (Dialysis Dependent)
- Status
- completed
- Trials
- 1